Patent details

Basic Information

Publication number:

EP0392059

PCT Application Number:

Type:

European Patent Granted for LU

Legal Status:

Expired

Application number:

EP891066573

PCT Publication Number:

First applicant's nationality:

Translation Language:

EPO Publication Language:

German

English Title of Invention:

Use of adamantane derivatives in the prevention and treatment of cerebral ischemia.

French Title of Invention:

Utilisation de dérivés de l'adamantane pour la prévention et le traitement de l'ischémie cérébrale.

German Title of Invention:

Verwendung von Adamantan-Derivaten zur PrÄvention und Behandlung der cerebralen IschÄmie.

SPC Number:

90988

Dates

Filing date:

14/04/1989

Grant date:

15/09/1993

EP Publication Date:

15/09/1993

PCT Publication Date:

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/10/1990

EP B1 Publication Date:

15/09/1993

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

14/04/2009

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

20/11/2002

 

 

Name:

MERZ PHARMA GMBH & CO. KGAA

Address:

ECKENHEIMER LANDSTRASSE 100-104, 60318, FRANKFURT, Germany (DE)

History of Owners

From:

14/04/1989

To:

19/11/2002

Name:

MERZ & CO. GMBH & CO.

Address:

ECKENHEIMER LANDSTRASSE 100-104, 60318, FRANKFURT, Germany (DE)

Agent

Name:

OFFICE FREYLINGER S.A.

From:

15/09/1993

Address:

Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)

To:

Inventor

1

Name:

Schatton Wolfgang, Dr.

Address:

Germany (DE)

2

Name:

Bormann Joachim, Dr.

Address:

Germany (DE)

3

Name:

Gold Markus R., Dr.

Address:

Germany (DE)

Classification

Main IPC Class:

A61K 31/13;

Filing date	Document type	Number of pages